- CTIC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
CTI BioPharma (CTIC) S-3Shelf registration
Filed: 31 Mar 08, 12:00am
Exhibit 12.1
STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(in thousands)
Year Ended December 31, | |||||||||||||||
2007 | 2006 | 2005 | 2004 | 2003 | |||||||||||
Net loss attributable to common shareholders | (148,305 | ) | (135,819 | ) | (102,505 | ) | (252,298 | ) | (130,031 | ) | |||||
Add: fixed charges | 15,421 | 45,147 | 18,942 | 12,504 | 10,694 | ||||||||||
Earnings as defined | (132,884 | ) | (90,672 | ) | (83,563 | ) | (239,794 | ) | (119,337 | ) | |||||
Fixed charges: | |||||||||||||||
Interest expensed and capitalized | 14,827 | 44,582 | 17,559 | 10,988 | 9,326 | ||||||||||
Estimated interest component of rent | 594 | 565 | 1,383 | 1,516 | 1,368 | ||||||||||
Total fixed charges | 15,421 | 45,147 | 18,942 | 12,504 | 10,694 | ||||||||||
Ratio of earnings to fixed charges | (1 | ) | (1 | ) | (1 | ) | (1 | ) | (1 | ) |
(1) | Earnings (as defined) for the period were insufficient to cover fixed charges by an amount equal to the net loss attributable to common shareholders for the period. |